AstraZeneca PLC (AZN)
64.26
+1.06
(+1.68%)
USD |
NASDAQ |
Nov 21, 16:00
65.74
+1.48
(+2.30%)
Pre-Market: 08:59
AstraZeneca Shareholders Equity (Quarterly): 40.72B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 40.72B |
June 30, 2024 | 39.51B |
March 31, 2024 | 37.44B |
December 31, 2023 | 39.14B |
September 30, 2023 | 37.20B |
June 30, 2023 | 37.39B |
March 31, 2023 | 35.79B |
December 31, 2022 | 37.04B |
September 30, 2022 | 35.13B |
June 30, 2022 | 35.93B |
March 31, 2022 | 36.34B |
December 31, 2021 | 39.27B |
September 30, 2021 | 39.74B |
June 30, 2021 | 15.68B |
March 31, 2021 | 14.43B |
December 31, 2020 | 15.62B |
September 30, 2020 | 12.20B |
June 30, 2020 | 12.24B |
March 31, 2020 | 10.78B |
December 31, 2019 | 13.13B |
September 30, 2019 | 12.16B |
June 30, 2019 | 13.55B |
March 31, 2019 | 10.48B |
December 31, 2018 | 12.47B |
September 30, 2018 | 11.94B |
Date | Value |
---|---|
June 30, 2018 | 12.64B |
March 31, 2018 | 12.92B |
December 31, 2017 | 14.96B |
September 30, 2017 | 13.72B |
June 30, 2017 | 13.65B |
March 31, 2017 | 12.99B |
December 31, 2016 | 14.85B |
September 30, 2016 | 13.07B |
June 30, 2016 | 13.53B |
March 31, 2016 | 14.74B |
December 31, 2015 | 18.49B |
September 30, 2015 | 17.35B |
June 30, 2015 | 18.28B |
March 31, 2015 | 16.94B |
December 31, 2014 | 19.63B |
September 30, 2014 | 20.44B |
June 30, 2014 | 22.03B |
March 31, 2014 | 21.45B |
December 31, 2013 | 23.22B |
September 30, 2013 | 23.25B |
June 30, 2013 | 23.22B |
March 31, 2013 | 22.29B |
December 31, 2012 | 23.73B |
September 30, 2012 | 22.04B |
June 30, 2012 | 22.03B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
10.78B
Minimum
Mar 2020
40.72B
Maximum
Sep 2024
29.24B
Average
36.14B
Median
Shareholders Equity (Quarterly) Benchmarks
GSK PLC | 18.75B |
Amgen Inc | 7.527B |
Johnson & Johnson | 70.16B |
Sanofi SA | -- |
Moderna Inc | 11.93B |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 104.92B |
Total Liabilities (Quarterly) | 64.12B |
Debt to Equity Ratio | 0.7402 |
Current Ratio | 0.9317 |
Net Debt Paydown Yield | -0.10% |